tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Lineage Therap Holds Annual Meeting, Elects Directors

Story Highlights
  • Lineage Therap’s shareholders elected seven directors and ratified Baker Tilly US, LLP as the accounting firm.
  • Shareholders approved executive compensation and an EIP Amendment, indicating support for current strategies.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Lineage Therap Holds Annual Meeting, Elects Directors

Elevate Your Investing Strategy:

Lineage Therap ( (LCTX) ) has provided an announcement.

On June 26, 2025, Lineage Therap held its Annual Meeting, where shareholders elected seven directors to the board, ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, approved executive compensation on an advisory basis, and approved an EIP Amendment. These decisions reflect shareholder support for the company’s current leadership and strategic direction, potentially impacting its governance and financial practices.

The most recent analyst rating on (LCTX) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Lineage Therap stock, see the LCTX Stock Forecast page.

Spark’s Take on LCTX Stock

According to Spark, TipRanks’ AI Analyst, LCTX is a Neutral.

Lineage Cell Therapeutics exhibits strengths in technical analysis and promising earnings call developments, particularly in key programs like OpRegen and OPC1. However, financial and valuation challenges typical of biotech firms weigh down the score, with negative profitability and reliance on external funding posing risks.

To see Spark’s full report on LCTX stock, click here.

More about Lineage Therap

Average Trading Volume: 2,202,714

Technical Sentiment Signal: Hold

Current Market Cap: $205M

See more insights into LCTX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1